Andrew Demchuk
Overview
Explore the profile of Andrew Demchuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ospel J, Brown S, Bosshart S, Stebner A, Uchida K, Demchuk A, et al.
J Am Heart Assoc
. 2025 Feb;
14(5):e037752.
PMID: 39968801
Background: We investigate whether the National Institutes of Health Stroke Scale (NIHSS) at 24 hours could serve as a primary outcome in acute ischemic stroke trials, and whether combining 90-day...
2.
Siddiqi A, Ignacio K, Kaveeta C, Bala F, Ademola A, Tkach A, et al.
J Stroke
. 2025 Feb;
27(1):113-117.
PMID: 39916460
No abstract available.
3.
Siddiqi A, Ignacio K, Kaveeta C, Bala F, Ademola A, Tkach A, et al.
J Am Heart Assoc
. 2024 Dec;
14(1):e037577.
PMID: 39704225
Background: About 25% of patients with acute ischemic stroke have lacunar infarct on follow-up imaging. In this secondary analysis from the AcT (Alteplase Compared With Tenecteplase) trial, we assessed if...
4.
Stebner A, Bosshart S, Demchuk A, Poppe A, Nogueira R, McTaggart R, et al.
Clin Neuroradiol
. 2024 Oct;
35(1):141-150.
PMID: 39404848
Purpose: The modified Rankin Scale (mRS) at 90 days is the primary outcome in most acute stroke studies, but the long follow-up period has disadvantages. The National Institutes of Health...
5.
Cimflova P, Ospel J, Singh N, Marko M, Kashani N, Mayank A, et al.
Interv Neuroradiol
. 2024 Oct;
30(6):804-811.
PMID: 39397754
Background: We evaluated the association of reperfusion quality and different patterns of achieved reperfusion with clinical and radiological outcomes in the ESCAPE NA1 trial. Methods: Data are from the ESCAPE-NA1...
6.
Pensato U, Demchuk A, Ospel J
Neurology
. 2024 Jul;
103(4):e209439.
PMID: 39052962
No abstract available.
7.
Ospel J, Dowlatshahi D, Demchuk A, Volders D, Mohlenbruch M, Nimjee S, et al.
Int J Stroke
. 2024 Jun;
19(9):1064-1070.
PMID: 38845180
Rationale: Clinical outcomes in acute ischemic stroke due to medium vessel occlusion (MeVO) are often poor when treated with best medical management. Data from non-randomized studies suggest that endovascular treatment...
8.
Bala F, Singh N, Ignacio K, Alhabli I, Ademola A, Alrohimi A, et al.
J Stroke
. 2024 Jun;
26(2):280-289.
PMID: 38836275
Background And Purpose: The safety and efficacy of tenecteplase in patients with ischemic stroke due to medium vessel occlusion (MeVO) are not well studied. We aimed to compare tenecteplase with...
9.
Ospel J, Rinkel L, Ganesh A, Demchuk A, Heran M, Sauvageau E, et al.
J Stroke
. 2024 Jun;
26(2):252-259.
PMID: 38836272
Background And Purpose: Infarct volume and other imaging markers are increasingly used as surrogate measures for clinical outcome in acute ischemic stroke research, but how improvements in these imaging surrogates...
10.
Joundi R, Smith E, Mandzia J, Ganesh A, Menon B, Rempel J, et al.
Neurology
. 2024 May;
102(10):e209270.
PMID: 38739880
Background And Objectives: The effect of endovascular therapy (EVT) for large vessel occlusion stroke on cognitive outcomes is not well understood. We evaluated the effect of EVT on cognitive function...